Wyeth and its licensing partner, Nycomed GmbH, are pursuing a lawsuit against Sandoz Inc. in the U.S. District Court for the Northern District of Illinois, alleging infringement of U.S. Patent…
Wyeth pursues a lawsuit against Sandoz Inc. in the U.S. District Court for the District of Delaware, alleging that Sandoz’s filing of Abbreviated New Drug Application with the U.S. Food…
The U.S. District Court for the Central District of California has ruled to extend for at least 90 days the September 2008 trial date in Wyeth’s patent infringement litigation against…
The REFACTO patent infringement litigation initiated by a subsidiary of Wyeth against Novartis Vaccines and Diagnostics, Inc. remains pending in the U.S. District Court for the District of Delaware.
On May…
Wyeth and its licensing partner, Nycomed GmbH, anticipate a trial for the Company’s PROTONIX patent infringement litigation in the U.S. District Court for the District of New Jersey will occur…
The U.S. District Court for the District of Delaware, on July 16, 2008, entered a consent judgment and dismissed Wyeth’s suit against Impax Laboratories, Inc. alleging infringement of three patents…
Wyeth and its licensing partner, Nycomed GmbH, pursue a patent infringement lawsuit against Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Parenteral Medicines, Inc. in the U.S. District…
Wyeth pursues a patent infringement litigation against Biovail Corporation, Biovail Laboratories International SRL and Biovail Technologies, Ltd. in the U.S. District Court for the District of Delaware.
The patents-at-issue are: U.S.…